Attached files
| file | filename |
|---|---|
| EX-4.1 - FORM OF WARRANT - SCIENTIFIC INDUSTRIES INC | finalwarrantform.htm |
| EX-4.2 - REGISTRATION RIGHTS AGREEMENT BY AND AMONG THE COMPANY AND THE INVESTORS - SCIENTIFIC INDUSTRIES INC | finalregrightsform.htm |
| EX-10.3 - PURCHASE AGREEMENT BY AND AMONG THE COMPANY AND THE INVESTORS - SCIENTIFIC INDUSTRIES INC | finalspaform.htm |
| EX-10.2 - FORM OF SERVICE AGREEMENT - SCIENTIFIC INDUSTRIES INC | directorserviceagreement.htm |
| EX-10.1 - ACQUISITION AGREEMENT BY AND AMONG THE COMPANY AND THE SELLERS - SCIENTIFIC INDUSTRIES INC | spafinal.htm |
| EX-99 - ADDITIONAL EXHIBITS - SCIENTIFIC INDUSTRIES INC | scndaquiresaquilabiolabsp.htm |
| 8-K - 8-K - SCIENTIFIC INDUSTRIES INC | a8kaquila-1.htm |
Scientific Industries Announces Appointment of Dr. Jürgen
Schumacher to the Board of Directors
BOHEMIA, NY and PITTSBURGH, PA /April 30, 2021
/ Scientific Industries,
Inc. (OTCQB: SCND) today
announced the appointment of Dr. Jürgen Schumacher to the
Company’s Board of Directors.
Dr.
Jürgen Schumacher is an internationally recognized German
entrepreneur with more than 35 years of expertise in the biotech
industry. Dr. Schumacher co-founded Qiagen AG, one of
Germany’s largest biotechnology companies, NewLab Bioquality
AG, which was acquired by Charles River Laboratories International
Inc., BiBiTech and Algiax Pharmaceuticals. Dr. Schumacher advises
and invests in promising biotech business models.
Dr. Schumacher holds a PhD in Biology from Heinrich Heine
University of Düsseldorf and a Diploma in Biology from
Technical University of Darmstadt.
John Moore, Chairman of Scientific Industries and President of
Scientific Bioprocessing, Inc. (SBI), said, “We are
delighted to welcome Dr. Schumacher as director on Scientific
Industries’ Board. Jürgen has built a distinguished
career within the biotechnology industry and his extensive industry
knowledge and experience will be a real asset to the Board. We look
forward to working with him in the successful combination of aquila
biolabs and Scientific Bioprocessing to create a new digital
platform that brings dramatic innovation to bioprocessing and
significantly enhances accuracy for improved
time-to-market.”
About Scientific Bioprocessing, Inc. (SBI)
SBI is dedicated to providing state-of-the-art instruments,
strategies, and technologies to expedite the production of viable
cells and therapies with a streamlined process and product
consistency. SBI’s mission is to develop sensor technologies
and instruments that make cell culture and bioprocessing work
easier, experiments more reproducible, and culture conditions
better suited to meet experimental objectives. SBI is a subsidiary
of Scientific
Industries, Inc. To learn more, visit
www.scientificbio.com.
About Scientific Industries, Inc.
Scientific Industries (OTCQB:SCND), is a life science tool
provider. It designs, manufactures, and markets laboratory
equipment, including the world-renowned
Vortex-Genie®
2 Mixer and
Torbal®
balances,
and bioprocessing systems and methods. Scientific Industries’
products are generally used and designed for research purposes in
laboratories of universities, hospitals, pharmaceutical companies,
medical device manufacturers, and pharmacies. To learn more,
visit www.scientificindustries.com.
Safe Harbor Statement
Statements
made in this press release that relate to future events,
performance or financial results of the Company are forward-looking
statements which involve uncertainties that could cause actual
events, performance or results to materially differ. The Company
undertakes no obligation to update any of these statements. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as to the date hereof. Accordingly,
any forward-looking statement should be read in conjunction with
the additional information about risks and uncertainties set forth
in the Company's Securities and Exchange Commission reports,
including our annual report on Form 10-K.
Contact:
Sandy Williams
Marketing and Product Manager
Scientific Bioprocessing, Inc.
412-230-8463
media@scientificbio.com
www.scientificbio.com
Investor Contact:
Joe Dorame
Lytham Partners, LLC
Phone: (602) 889-9700
SCND@lythampartners.com
###